Thrombin up-regulates vascular endothelial growth factor in experimental gliomas

References

• Hua Y, Keep RE, Schallert T, et al. A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model. Acta Neurochir Suppl 2003; 86: 503–506
   PubMedGoogle Scholar
• Hua Y, Tang L, Keep RE, et al. The role of thrombin in gliomas. J Thromb Haemost 2005; 3: 1–7
   PubMedGoogle Scholar
• Hua Y, Tang LL, Fewel ME, et al. Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models. Acta Neurochir SuppI 2005; 95: 403-406
   PubMedGoogle Scholar
• Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothe-lial growth factor activity on endothelial cells by up-regulation of its receptors. Biol Chem 1999; 274: 23969–23976
   Web of Science ®Google Scholar
• Yamahata H, Takeshima H, Kuratsu J, et al. The role of thrombin in the neo-vascularization of malignant gliomas: An intrinsic mod-ulator for the up-regulation of vascular endothelial growth factor. Int J Oncol 2002; 20: 921–928
   PubMed Web of Science ®Google Scholar
• Sarker KP, Biswas KK, Yamaji K, et al. Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (nb-1) cells by argatroban. Pathophysiol Haemost Thromb 2005; 34: 41–47
   PubMedGoogle Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25
   PubMed Web of Science ®Google Scholar
• Berse B, Brown LE, van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3: 211–220
   PubMed Web of Science ®Google Scholar
• Damert A, Machein M, Breier G, et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997; 57: 3860–3864
   PubMed Web of Science ®Google Scholar
• Jensen RL, Ragel BT, Whang K, et al. Inhibition of hypoxia inducible factor-1 alpha (HE-1alpha) decreases vascular endothe-lial growth factor (VEGF) secretion and tumor growth in malignant gliomas. I Neurooncol 2006; 78: 233–247
   PubMed Web of Science ®Google Scholar
• Berra E, Pages G, Pouyssegur J. MAP kinases and hypoxia in the control of VEGF expression. Cancer Metast Rev 2000; 19: 139–145
   PubMed Web of Science ®Google Scholar
• Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765–26771
   PubMed Web of Science ®Google Scholar
• Hanze J, Eul BG, Savai R, et al. RNA interference for HIE-1alpha inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Commun 2003; 312: 571–577
   PubMed Web of Science ®Google Scholar
• Hua Y, Keep RE, Hoff JT, et al. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. Cereb Blood Flow Metab 2003; 23: 1448–1454
   PubMed Web of Science ®Google Scholar
• Mizoguchi M, Betensky RA, Batchelor TT, et al. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 2006; 65: 1181–1188
   PubMed Web of Science ®Google Scholar
• Xi G, Keep RE, Hua Y, et al. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 1999; 30: 1247–1255
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wu J, Keep RE, et al. Hypoxia-inducible factor-1a accumulation in the brain after experimental intracerebral hemorrhage. I Cereb Blood Flow Metab 2002; 22: 689–696
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E, Kisiel W. The role of hemostatic system inhibitors in malignancy. Semin Thromb Hemost 2007; 33: 621–642
   PubMed Web of Science ®Google Scholar
• Xi G, Reiser G, Keep RE. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: Deleterious or protective? I Neurochem 2003; 84: 3–9
   PubMed Web of Science ®Google Scholar
• Coughlin SR. Thrombin signalling and protease-activated recep-tors. Nature 2000; 407: 258–264
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Tang DG, Ben-Josef E, et al. Solid tumor cells express functional “tethered I igand” thrombin receptor. Cancer Res 1995; 55: 698–704
   PubMed Web of Science ®Google Scholar
• Tsopanoglou NE, Maragoudakis ME. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. Semin Thromb Hemost 2007; 33: 680–687
   PubMed Web of Science ®Google Scholar
• Weich HA, Iberg N, Klagsbrun M, et al. Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. I Cell Biochem 1991; 47: 158–164
   PubMed Web of Science ®Google Scholar
• Fischer I, Gagner JP, Law M, et al. Angiogenesis in gliomas: Biology and molecular pathophysiology. Brain Pathol 2005; 15: 297–310
   PubMed Web of Science ®Google Scholar
• Zagzag D, Zhong H, Scalzitti JM, et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 2000; 88: 2606–2618
   PubMed Web of Science ®Google Scholar
• Zhong H, de Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830–5835
   PubMed Web of Science ®Google Scholar
• Lee KR, Kawai N, Kim S, et al. Mechanisms of edema formation after intracerebral hemorrhage: Effects of thrombin on cerebral blood flow, blood—brain barrier permeability, and cell survival in a rat model. ] Neurosurg 1997; 86: 272–278
   PubMed Web of Science ®Google Scholar
• Berra E, Milanini J, Richard DE, et al. Signaling angiogenesis via p42/p44 map kinase and hypoxia. Biochem Pharmacol 2000; 60: 1171–1178
   PubMed Web of Science ®Google Scholar
• Birner P, Gatterbauer B, Oberhuber G, et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: Its impact on prognosis and on neoangiogenesis. Cancer 2001; 92: 165–171
   PubMed Web of Science ®Google Scholar
• Sodhi A, Montaner S, Miyazaki H, et al. MAPK and AKT act cooperatively but independently on hypoxia inducible factor-1alpha in rasv12 upregulation of VEGF. Biochem Biophys Res Commun 2001; 287: 292–300
   PubMed Web of Science ®Google Scholar
• Maragoudakis ME, Tsopanoglou NE, Andriopoulou P, et al. Effects of thrombin/thrombosis in angiogenesis and tumour progression. Matrix Biol 2000; 19: 345–351
   PubMed Web of Science ®Google Scholar
• Tsopanoglou NE, Maragoudakis ME. Role of thrombin in angiogenesis and tumor progression. Semin Thromb Hemost 2004; 30: 63–69
   PubMed Web of Science ®Google Scholar
• Tsopanoglou NE, Papaconstantinou ME, Flordellis CS, etal. On the mode of action of thrombin-induced angiogenesis: Thrombin peptide, tp508, mediates effects in endothelial cells via alphav-beta3 integrin. Thromb Haemost 2004; 92: 846–857
   PubMed Web of Science ®Google Scholar
• Fang J, Yan L, Shing Y, et al. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 2001; 61: 5731–5735
   PubMed Web of Science ®Google Scholar